Matching slides 24,547
Current window 17,221-17,250
Pages 819
Rows per page 30
Slide function: Present Solutionclear collectionreset all

Slide function

17,221-17,250 of 24,547

filter-aware
03
The slide uses a vertical bracket to group three key pillars under the umbrella of 'GENETICS'.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Loop · Logic Chain1 hit
12
The slide uses a process flow diagram to explain the 'POWER' methodology.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Logic Chain1 hit
14
The slide uses a process flow to demonstrate the predictive power of their genomic platform.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
15
FxG likely stands for Functional Genomics. The slide uses a process flow diagram to illustrate the R&D pipeline.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
17
23andMe | Investor Presentation Deck | 39 slides23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
24
The slide uses a three-column layout to present pharmacology, mechanism of action (diagram), and clinical development status.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
28
The chart demonstrates superior efficacy of 23ME-00610 over anti-PD1 in stimulating IFNy across multiple cancer types.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
29
The chart shows statistical significance (p<0.01 and p<0.0001) for the combination therapy.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
32
The slide uses a combination of a data table, a biological mechanism diagram, and a summary of clinical validation to support the therapeutic thesis.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
33
The slide uses a combination of a biological process diagram and a line chart showing tumor cell reduction over time.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
36
Uses a Venn-like diagram to show genetic overlap between asthma and other conditions (COPD, eczema, neuro-inflammation, urticaria) to drive specific R&D strategies.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
04
The graphic is a stylized geometric representation of an engine or platform.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
10
The slide uses a two-column layout to present the value proposition of the platform.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
11
The slide demonstrates a therapeutic window improvement by comparing efficacy (killing) vs safety (cytokine release) across concentration gradients.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
06
The slide illustrates a process flow from target antigen to AI-designed antibodies.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
07
The slide uses a circular process diagram to link AI design with wet-lab validation.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
08
The slide uses a linear process flow with icons representing the transformation of biological inputs through AI models.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
09
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
23
The slide outlines a standard clinical trial protocol structure.Alkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
03
The slide uses a simple icon-based visual to anchor the core strategic goal.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
08
The slide uses a process-oriented flow diagram to explain the therapeutic strategy.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
10
The slide highlights the mechanism of action and key benefits of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
21
The slide uses a three-column layout to explain the scientific basis and product advantages.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
16
The slide uses a circular/arc layout to categorize assets into 'Immunology Innovation Program', 'Pipeline', and 'VYVGART Opportunity'.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · The BreakthroughLoop · Quick Win Big Bet1 hit
20
The slide uses an infinity-loop style diagram to represent a continuous process or interconnected concepts.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · The BreakthroughLoop · Quick Win Big Bet1 hit
79
The slide features a large photograph of a Thom Browne store entrance.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
83
Zegna | Investor Day Presentation Deck | 150 slidesZegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
103
The slide uses a Venn diagram to show brand consolidation and a perceptual map to show competitive positioning.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
104
Uses a waterfall-style arrow to show SKU reduction and a process arrow to show product line consolidation.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
105
The slide uses a visual hierarchy connecting product icons to strategic pillars.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit